Krka Logo

Krka

KRKG | LJSE

Overview

Corporate Details

ISIN(s):
SI0031102120
LEI:
549300H9RLRTRTLRUZ73
Country:
Slovenia
Address:
Šmarješka cesta 006, 8501 Novo mesto
Sector:
Health Care
Industry:
Pharmaceuticals

Description

Krka’s basic line of business is the production and sale of prescription pharmaceuticals, non-prescription products and animal health products. The company's focus is on the development of high-quality own-brand generic pharmaceuticals, which offer added value, and are marketed under Krka's own brands. Our products are sold in over 70 countries. As part of our business strategy we have set the objective of balanced sales in five different regions: Slovenia, Central Europe, South-East Europe, East Europe, West Europe and Overseas Markets.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-06 08:30
Proxy Solicitation & Information Statements
Pooblastilo za glasovanje na 31. skupščini delničarjev
Slovene 931.8 KB
2025-06-06 08:30
Declaration of Voting Results & Voting Rights Announcements
Organizirano zbiranje pooblastil za uresničevanje glasovalnih pravic
Slovene 2.6 KB
2025-05-28 08:30
Transaction in Own Shares
Share buy-back programme schedule from July to December 2025
English 83.9 KB
2025-05-28 08:30
Transaction in Own Shares
Share buy-back programme schedule from July to December 2025
English 1.6 KB
2025-05-28 08:30
Transaction in Own Shares
Terminski načrt programa odkupa lastnih delnic v drugem polletju 2025
English 110.8 KB
2025-05-28 08:30
Transaction in Own Shares
Terminski načrt programa odkupa lastnih delnic v drugem polletju 2025
Slovene 1.5 KB
2025-05-16 08:30
Proxy Solicitation & Information Statements
Proxy statement
English 76.5 KB
2025-05-16 08:30
Registration Form
Registration form
English 75.1 KB
2025-05-16 08:30
Proxy Solicitation & Information Statements
Shareholder rights
English 157.8 KB
2025-05-16 08:30
Remuneration Report
Report on remuneration of management and supervisory board members 2024
English 564.5 KB
2025-05-16 08:30
Declaration of Voting Results & Voting Rights Announcements
Explanation of proposed resolutions
English 240.1 KB
2025-05-16 08:30
General Meeting Notice
31 AGM notice
English 218.6 KB
2025-05-16 08:30
General Meeting Notice
31st Annual General Meeting notice
English 1.2 KB
2025-05-16 08:30
Interim Report
Q1 2025 Unaudited Interim Report of the Krka Group and Krka Company
English 1.0 MB
2025-05-16 08:30
Earnings Release
Press release
English 148.3 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ABIVAX Logo ABIVAX France ABVX
Addex Therapeutics Ltd Logo Addex Therapeutics Ltd Switzerland ADXN
AegirBio AB Logo AegirBio AB Sweden AEGIR
AGRONOMICS LIMITED Logo AGRONOMICS LIMITED Isle of Man ANIC
AIREA PLC Logo AIREA PLC United Kingdom AIEA
Alkaloid AD Logo Alkaloid AD North Macedonia ALK
Alma Yesodot Ltd. Israel KVSR
Antibiotice S.A. Logo Antibiotice S.A. Romania ATB
Aran Research & Development (1982) Ltd. Logo Aran Research & Development (1982) Ltd. Israel ARAN
Asarina Pharma AB Logo Asarina Pharma AB Sweden ASAP